Department of Pediatrics, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao tong University School of Medicine, Shanghai, China.
Respiratory department, Shanghai Children's Hospital, Affiliated to Shanghai Jiao tong University School of Medicine, Shanghai, China.
NPJ Prim Care Respir Med. 2023 Mar 13;33(1):10. doi: 10.1038/s41533-023-00332-z.
Asthma is closely associated with inflammation. We evaluated the predictive and prognostic value of leptin status in asthma. We searched the electronic databases for articles that determined the leptin level in asthma cases through May 2020. We compared the differences of leptin level between asthma and non-asthma controls, as well as between severe and mild asthma cases. We also investigated the impact of age and gender on these differences by using meta-regression analysis. 59 studies were included in our pooled analysis. Asthma cases demonstrated significantly higher leptin level than that in non-asthma controls among overall populations (SMD:1.061, 95% CI: 0.784-1.338, p < 10), Caucasians (SMD:0.287, 95% CI: 0.125-0.448, p = 0.001), Asians (SMD:1.500, 95% CI: 1.064-1.936, p < 10) and Africans (SMD: 8.386, 95% CI: 6.519-10.253, p < 10). Severe asthma cases showed markedly higher leptin level than that in mild asthma cases among overall populations (SMD:1.638, 95% CI: 0.952-2.323, p < 10) and Asians (SMD:2.600, 95% CI: 1.854-3.345, p < 10). No significant difference of leptin level between severe and mild asthma was observed in Caucasians (SMD:-0.819, 95% CI: -1.998-0.360, p = 0.173). Cumulative analyses yielded similar results regarding the difference of leptin status between asthma and non-asthma controls, as well as between severe and mild asthma cases among overall populations. Age and male/ female ratio were not associated with the difference of leptin status between asthma and non-asthma controls (coefficient:-0.031, 95% CI: -0.123-0.061, p = 0.495; coefficient:0.172, 95% CI: -2.445-2.789, p = 0.895), as well as between severe and mild asthma cases among overall populations (coefficient:-0.072, 95% CI: -0.208-0.063, p = 0.279; coefficient: 2.373, 95% CI: -0.414-5.161, p = 0.090). Asthma demonstrated significantly higher level of leptin than that in non-asthma controls among overall populations, Caucasians, Asians and Africans. Severe asthma cases showed markedly higher leptin level than that in mild cases among overall populations and Asians. Leptin may be a risk predictor and prognostic marker of asthma. Early monitoring and intervention of leptin may be needed for asthma.
哮喘与炎症密切相关。我们评估了瘦素状态在哮喘中的预测和预后价值。我们通过电子数据库检索了截至 2020 年 5 月确定哮喘病例瘦素水平的文章。我们比较了哮喘与非哮喘对照组、重度与轻度哮喘病例之间瘦素水平的差异,并通过元回归分析研究了年龄和性别对这些差异的影响。共有 59 项研究纳入我们的汇总分析。在总体人群中,哮喘病例的瘦素水平明显高于非哮喘对照组(SMD:1.061,95%CI:0.784-1.338,p<0.001)、白种人(SMD:0.287,95%CI:0.125-0.448,p=0.001)、亚洲人(SMD:1.500,95%CI:1.064-1.936,p<0.001)和非洲人(SMD:8.386,95%CI:6.519-10.253,p<0.001)。在总体人群中,重度哮喘病例的瘦素水平明显高于轻度哮喘病例(SMD:1.638,95%CI:0.952-2.323,p<0.001)和亚洲人(SMD:2.600,95%CI:1.854-3.345,p<0.001)。在白种人中,重度与轻度哮喘病例的瘦素水平无显著差异(SMD:-0.819,95%CI:-1.998-0.360,p=0.173)。累积分析得到了关于哮喘与非哮喘对照组以及重度与轻度哮喘病例之间瘦素状态差异的相似结果。年龄和男女比例与哮喘与非哮喘对照组之间(系数:-0.031,95%CI:-0.123-0.061,p=0.495;系数:0.172,95%CI:-2.445-2.789,p=0.895)以及重度与轻度哮喘病例之间(系数:-0.072,95%CI:-0.208-0.063,p=0.279;系数:2.373,95%CI:-0.414-5.161,p=0.090)的瘦素状态差异无关。哮喘患者的瘦素水平明显高于非哮喘患者,白种人、亚洲人和非洲人也存在这种情况。在总体人群和亚洲人中,重度哮喘病例的瘦素水平明显高于轻度哮喘病例。瘦素可能是哮喘的风险预测因子和预后标志物。可能需要对哮喘患者进行早期的瘦素监测和干预。